1. Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway
   Ya-Jia Xie et al, 2020, Pharmacological Research CrossRef
2. Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells
   István Csomós et al, 2021, International Journal of Molecular Sciences CrossRef
3. Greater Celandine's Ups and Downs−21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology
   Sylwia Zielińska et al, 2018, Frontiers in Pharmacology CrossRef
4. Optimization of Formulation Technology for Gastric Floating Tablets of total alkaloids from Chelidonium majus L.
   Z Y Qu et al, 2018, IOP Conference Series: Materials Science and Engineering CrossRef
5. Tap the sap – investigation of latex-bearing plants in the search of potential anticancer biopharmaceuticals
   Oliwia Mazur et al, 2022, Frontiers in Plant Science CrossRef
6. Morphologic and Immunohistochemical Appraisal of Primary Gastric Carcinomas
   Gunes Guner et al, 2018, Applied Immunohistochemistry & Molecular Morphology CrossRef
7. Phytochemistry and pharmacology of alkaloids from Glaucium spp.
   Toktam Akaberi et al, 2021, Phytochemistry CrossRef
8. Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells
   Hyun-Jin Jang et al, 2021, Integrative Cancer Therapies CrossRef
9. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives
   Qichao Hu et al, 2023, Phytotherapy Research CrossRef
10. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis
    Chuanyou Yi et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
11. Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine
    Ling Qian et al, 2020, Clinical Cancer Research CrossRef